Transient Unilateral Weakness: TIA, Minor Stroke, or Mimic?

Learning objectives#

• Treat resolved focal neurologic symptoms as a time-sensitive neurovascular syndrome rather than a completed benign event.
• Distinguish TIA, minor ischemic stroke, intracranial hemorrhage, seizure, migraine, hypoglycemia, and peripheral mimics through chronology and targeted testing.
• Use brain and head-and-neck vascular imaging to identify tissue injury and treatable arterial disease.
• Apply antiplatelet, anticoagulation, carotid, lipid, blood-pressure, and rhythm strategies according to mechanism rather than one universal bundle.
• Build a rapid-disposition and follow-up system that does not depend on a risk score alone.

Initial presentation#

Priya, a 59-year-old accountant, is eating breakfast when her coffee cup slips from her left hand. Her husband notices that the left side of her mouth droops and that her words sound hesitant. Priya understands him but struggles to name the spoon on the table. She tries to stand and feels that the left leg is less reliable. Her husband notes the exact time, calls emergency services, and does not drive her.

By the time paramedics arrive twelve minutes later, speech is improving. Finger-stick glucose is normal. Blood pressure is 176/96 mm Hg, pulse 78 and regular, oxygen saturation normal, and no seizure activity is observed. During transport, facial symmetry returns and left-arm strength becomes normal. Total symptom duration is about twenty-two minutes.

Priya wants to cancel the ambulance because she now feels well. Paramedics explain that resolution is compatible with a transient ischemic attack or small stroke and that treatment opportunities depend on rapid evaluation. A prehospital stroke notification is sent with last-known-well time, symptom sequence, anticoagulant status, glucose, vital signs, and current examination.

Her history includes hypertension, high cholesterol, migraine without aura in her twenties, and cigarette use that stopped five years earlier. She takes one blood-pressure medicine inconsistently because it causes ankle swelling and has not taken a lipid-lowering medicine after reading about muscle adverse effects online. She has no known atrial fibrillation, diabetes, prior stroke, seizure, cancer, or recent trauma. She is not taking an antiplatelet or anticoagulant. Her older brother had a stroke at age sixty-one.

At emergency arrival, she is alert, fluent, and able to name objects. Cranial nerves, visual fields, strength, sensation, coordination, and gait are normal. A standardized stroke scale is zero. There is no headache, neck pain, chest pain, or ongoing deficit. A normal score documents the current examination; it does not reconstruct the witnessed episode or exclude an infarct in a function not captured well by the scale.

Problem representation#

This is a 59-year-old adult with vascular risk factors and sudden negative focal neurologic symptoms (left facial, arm, and leg weakness with language dysfunction) that began at a known time, peaked immediately, and resolved within twenty-two minutes. Glucose was normal, there was no positive spreading sensory phenomenon or witnessed seizure, and the symptom cluster localizes to the right cerebral hemisphere, although language laterality and the precise vascular territory require imaging.

The leading diagnosis is transient cerebral ischemia, with TIA versus minor ischemic stroke determined partly by tissue imaging. Early recurrence risk is clinically important even though the examination is now normal. Brain hemorrhage and mimics must be excluded, and vascular imaging is urgent because a symptomatic carotid lesion or intracranial stenosis could change immediate management.

Prioritized differential#

1. Transient ischemic attack or minor ischemic stroke#

Abrupt maximal-onset unilateral weakness and language dysfunction are classic negative focal deficits. Hypertension, lipids, prior tobacco use, and family history increase vascular probability. Resolution does not determine whether tissue infarction occurred.

2. Large-artery atherosclerotic disease#

Carotid plaque can generate emboli causing transient cortical deficits. Head-and-neck vascular imaging is therefore not an optional outpatient afterthought. Intracranial atherosclerosis is another mechanism, particularly across diverse populations, and produces different procedural evidence.

3. Cardioembolism#

Paroxysmal atrial fibrillation may be absent on one electrocardiogram. Structural heart disease, atrial cardiopathy, recent infarction, valve disease, or intracardiac thrombus may also matter. Rhythm history, electrocardiography, telemetry, echocardiography, and longer monitoring are selected according to the initial workup.

4. Small-vessel ischemia#

Hypertension can produce a lacunar syndrome, but cortical language dysfunction and a face-arm-leg pattern do not fit every small-vessel territory. MRI anatomy helps. Mechanism should not be assigned solely from risk factors.

5. Focal seizure with postictal weakness#

Positive motor activity, forced head or eye deviation, automatisms, impaired awareness, tongue injury, incontinence, or postictal confusion would support seizure. None was observed. Isolated postictal weakness remains possible, but abrupt negative symptoms without a seizure sequence favor ischemia.

6. Migraine aura#

Migraine aura often evolves over minutes with positive visual or sensory symptoms that spread, sometimes followed by headache. Priya's remote migraine lacked aura, and the present deficit was sudden, negative, and simultaneous. Age and new pattern raise the threshold for calling it migraine.

7. Metabolic, toxic, peripheral, and functional mimics#

Hypoglycemia was excluded early. Electrolyte disturbance, drug effects, tumor, subdural collection, demyelination, Bell palsy, cervical radiculopathy, and functional neurologic symptoms can mimic parts of the event. Combined face, arm, leg, and language dysfunction is not explained by one peripheral lesion. A functional diagnosis would require positive compatible signs, not simply normal imaging.

Focused history and examination#

The clinician interviews Priya and her husband separately enough to preserve the observed sequence. They establish exact last known well, first symptom, time to peak, duration, progression, residual deficit, prior similar episodes, headache, neck pain, seizure features, trauma, infection, pregnancy potential where relevant, and antithrombotic use. Witness description is essential because the examination normalized.

Vascular history includes hypertension, diabetes, lipids, tobacco, sleep apnea, kidney disease, coronary and peripheral disease, pregnancy-associated vascular history, migraine aura, cancer, thrombosis, and family history. Cardiac questions address palpitations, fainting, exercise intolerance, prior rhythm recordings, valve disease, recent infarction, and stimulant use. Medication access and adverse effects are documented rather than reduced to adherence.

Examination repeats a standardized neurologic assessment and also tests language, neglect, visual fields, fine hand function, gait, and cognition beyond the score. Heart rhythm, murmurs, pulse symmetry, carotid bruit, blood pressure, and vascular signs are assessed. A bruit neither measures stenosis nor identifies the symptomatic side; absence does not exclude severe disease.

Diagnostic strategy#

Keep the acute stroke pathway active#

Resolved symptoms do not erase treatment eligibility if a disabling deficit recurs or persists. The stroke team reviews onset, current findings, imaging, bleeding risk, medicines, and acute-treatment criteria through the 2026 pathway. Because Priya currently has no deficit, thrombolysis is not given simply to prevent a future event. If symptoms recur in the treatment window, she is reassessed immediately rather than told that the earlier resolution settled the question.

Noncontrast head CT shows no hemorrhage, mass effect, or established large infarct. This is important but does not exclude small acute ischemia. CT angiography of the head and neck shows an irregular high-grade stenosis at the right internal carotid origin without large-vessel intracranial occlusion. The exact percentage is confirmed using the local validated measurement method because treatment evidence depends on symptomatic status, degree, anatomy, sex, disability, comorbidity, and procedural risk.

MRI with diffusion-weighted imaging later shows several small acute right hemispheric cortical infarcts. The tissue finding changes the final label from TIA to minor ischemic stroke despite complete clinical resolution. The distribution supports artery-to-artery embolism from the ipsilateral carotid plaque.

Evaluate mechanism and treatment safety#

Electrocardiography shows sinus rhythm. Telemetry is started, and laboratory testing includes glucose, glycated hemoglobin, blood count, platelets, electrolytes, kidney and liver measures, coagulation studies when relevant to treatment, and lipids. Troponin is selected according to the stroke and cardiac context. Echocardiography is planned because finding a cardiac source would change management, but it does not delay action on clearly symptomatic carotid disease.

Risk scores are calculated only as supporting descriptions. Priya's age, pressure, unilateral weakness, and duration produce a concerning score, but the more decisive information is the diffusion-positive infarction and high-grade symptomatic carotid lesion. A low score would not make those findings safe for delayed follow-up.

The team also checks for repeated transient episodes during the preceding week because a crescendo pattern increases concern and can reveal a hemodynamically unstable arterial lesion. Orthostatic pressure is not used to provoke another deficit, but hydration, recent antihypertensive changes, anemia, and periods of low perfusion are reviewed. If symptoms had been stereotyped brief limb shaking without seizure features, severe carotid occlusive disease and hypoperfusion would be considered alongside focal epilepsy. This reinforces that the symptom label alone does not determine mechanism.

Separate vascular territories and mimics#

Vascular imaging includes both head and neck because extracranial and intracranial disease have different interventions. MRI can identify infarct pattern and some mimics but may be unavailable, delayed, or contraindicated. A negative MRI does not prove that a classic transient focal syndrome was nonischemic; the entire presentation and vascular findings remain relevant.

Progressive results and interpretation#

Priya remains neurologically normal, but the team treats this as a high-risk early period. Antiplatelet therapy begins after hemorrhage is excluded. Short-course dual antiplatelet therapy is considered appropriate under the selected minor noncardioembolic stroke pathway, after bleeding risk, timing, infarct burden, and planned carotid procedure are coordinated. Exact agents and duration follow the stroke and surgical teams; dual therapy is not indefinite.

High-intensity lipid lowering is discussed and started with a plan for adverse-effect assessment rather than assuming that an internet concern makes treatment impossible. Blood pressure is managed cautiously in the acute phase according to neurologic status and intervention plans. Long-term control is essential, but aggressive immediate reduction can affect cerebral perfusion. Tobacco abstinence, diabetes assessment, activity, sleep, and diet enter secondary prevention.

Vascular surgery and stroke neurology agree that the right carotid lesion is symptomatic and anatomically suitable for revascularization. The timing and procedure are selected after infarct size, neurologic stability, stenosis confirmation, sex-specific evidence, perioperative risk, cardiac status, and patient preference are reviewed. Priya undergoes uncomplicated carotid endarterectomy during the early prevention window. This outcome is not a claim that every stenosis needs surgery or that stenting and surgery are interchangeable.

Telemetry does not reveal atrial fibrillation, and echocardiography shows no high-risk embolic source. Outpatient rhythm monitoring is arranged because a single normal tracing cannot exclude paroxysmal AF, but the identified symptomatic carotid mechanism already explains the event. If AF were later found, antithrombotic strategy would be revisited rather than simply adding anticoagulation to every existing agent.

Management plan#

Prevent the next event while defining the cause#

Antiplatelet treatment is started after hemorrhage is excluded for a presumed noncardioembolic event. Evidence supports early time-limited dual therapy in selected high-risk TIA and minor stroke populations, with most benefit early and bleeding accumulating with longer exposure. Eligibility depends on timing, severity, mechanism, imaging, bleeding risk, and planned procedures. Long-term dual therapy is not the default.

If atrial fibrillation or another cardioembolic source were identified, anticoagulation timing would follow infarct size, hemorrhage risk, renal function, and the specific condition. Antiplatelet therapy is not an adequate substitute for AF-related stroke prevention, and unexamined combination therapy increases bleeding.

Treat symptomatic carotid disease through an organized pathway#

Carotid intervention benefits selected patients with recently symptomatic stenosis, but the degree of stenosis, patient characteristics, disability, anatomy, life expectancy, and perioperative outcomes matter. Imaging must be reliable, the lesion must match the event, and timing must balance early recurrence against procedural risk. Intracranial stenosis follows different evidence and should not be treated by importing extracranial-carotid assumptions.

Control vascular risk without losing the patient in targets#

Blood pressure, lipids, diabetes, tobacco, physical activity, diet, weight, sleep apnea, and medication access are addressed. Priya's ankle edema led to inconsistent use of one antihypertensive, so the plan changes the regimen rather than repeats the same instruction. Lipid therapy includes baseline symptoms, interaction review, and a route for genuine intolerance. Rehabilitation screening is still performed despite a normal examination because subtle fatigue, cognition, dexterity, mood, and confidence can affect return to work.

Escalation, referral, and safety net#

Any recurrent facial droop, limb weakness or numbness, speech difficulty, vision loss, severe imbalance, neglect, or sudden focal symptom triggers emergency services immediately. Priya is told not to wait for symptoms to last a set number of minutes and not to drive herself. Improvement while the ambulance is coming is not a reason to cancel it.

In hospital, recurrence prompts immediate stroke-team reassessment for acute reperfusion or large-vessel treatment based on current deficit, time, imaging, and eligibility. New headache, vomiting, reduced consciousness, or pressure change also raises hemorrhage and other complications. Carotid intervention planning is expedited rather than assigned to a routine referral queue.

After discharge, bleeding on antithrombotic therapy, new neurologic symptoms, severe headache, chest symptoms, or medication intolerance has a named response route. Primary care, stroke clinic, vascular surgery, and pharmacy agree who owns each pending test and medication transition.

Communication, shared decisions, and equity#

The clinician explains: "The symptoms stopping is good, but it does not mean nothing happened. The MRI shows several tiny areas of stroke, and the artery supplying that side has a severe narrowing that can send another clot. We are acting now because the chance of another event is highest early."

Priya and her husband are shown the difference between symptom-based TIA and tissue-confirmed stroke without suggesting that she caused the event by delaying a cholesterol medicine. The earlier concern about muscle effects is addressed with absolute benefits, common and serious adverse effects, alternatives, and a plan to evaluate symptoms rather than dismiss them.

Language, transportation, caregiving, work, prescription coverage, and digital access determine whether a rapid outpatient pathway is real. A risk score cannot compensate for unavailable imaging or a clinic that cannot see the patient. Written instructions are in the preferred language, and teach-back uses symptom demonstrations rather than acronyms alone.

Driving and work advice follows local law and functional assessment; the team does not invent a universal restriction. Priya is included in carotid-procedure decisions with an interpreter if needed and has time to ask about surgery, stenting, medical therapy, perioperative stroke, cranial-nerve injury, bleeding, and restenosis.

Follow-up and contingencies#

The discharge summary records exact symptom timing, witnessed deficits, current normal examination, CT and MRI findings, vascular anatomy, mechanism assessment, procedure, antithrombotic sequence, lipid and pressure plan, and pending rhythm monitoring. It names who will stop dual therapy at the intended time and who will act on rhythm results.

Stroke follow-up assesses recurrent symptoms, cognition, fatigue, mood, sleep, fine motor function, blood pressure, lipids, tobacco, exercise, and medicine tolerance. Primary care reconciles all prescriptions after the procedure and avoids duplicate antithrombotics. Vascular surveillance follows the procedural plan.

If prolonged monitoring finds atrial fibrillation, the team revisits mechanism and anticoagulation rather than leaving an alert unread. If the MRI had been negative but the syndrome and carotid lesion remained convincing, urgent prevention would still be required. If imaging showed no cause, cryptogenic-stroke evaluation would proceed in a staged manner, not through indiscriminate thrombophilia and cancer testing.

Reasoning traps and alternative pathways#

• Reassurance from symptom resolution: The risk of recurrence may be highest soon after a transient event.
• Calling a normal CT a stroke rule-out: CT is insensitive to small acute ischemia.
• Letting a zero stroke score erase the history: Scales document selected current deficits and can miss resolved or subtle dysfunction.
• Using ABCD2 as a discharge rule: Tissue and vascular imaging, mechanism, recurrent events, and follow-up feasibility matter.
• Calling every transient symptom TIA: Migraine, seizure, glucose disturbance, and other mimics require positive evaluation.
• Calling every mimic when MRI is negative: TIA can be tissue negative; diagnosis remains clinical and mechanistic.
• Giving dual antiplatelet therapy indefinitely: Benefit is population- and time-specific, while bleeding accumulates.
• Using antiplatelet therapy for atrial fibrillation: Cardioembolic prevention requires a different strategy.
• Finding carotid disease without matching the territory: Incidental stenosis should not be labeled symptomatic automatically.
• Delaying vascular imaging until a routine clinic visit: A treatable symptomatic lesion can carry early recurrence risk.

An alternative patient with persistent disabling deficit could be eligible for thrombolysis or thrombectomy under the acute pathway. A patient with hemorrhage would need a different pressure and hemostatic strategy. Positive spreading symptoms followed by headache might favor migraine, while witnessed jerking and postictal confusion could favor seizure. Posterior-circulation symptoms require careful assessment because common scores and examinations can underrepresent them. AF would shift long-term therapy toward anticoagulation.

Evidence limits and what could change#

TIA remains a clinical diagnosis with imperfect agreement. MRI improves tissue detection but availability, timing, magnet strength, lesion size, and posterior circulation affect sensitivity. Tissue-based definitions improve precision but should not deny urgency to a classic transient syndrome with negative imaging.

Risk scores were derived in specific cohorts and may perform differently across systems and populations. They do not include every high-risk mechanism. Rapid specialist pathways can safely avoid admission for selected patients only when brain and vascular imaging, treatment, monitoring, and follow-up are genuinely available.

Dual-antiplatelet trials enrolled defined minor-stroke or high-risk-TIA populations and used particular agents, timing, and durations. Results should not be extrapolated to major stroke, hemorrhage, anticoagulation indications, very late presentation, or indefinite treatment. Carotid intervention evidence also depends on stenosis measurement, symptoms, anatomy, patient characteristics, timing, and local procedural outcomes.

Acute stroke treatment is evolving, including thrombolytic choice, thrombectomy windows and populations, mobile stroke units, and imaging selection. The enduring principle is to treat sudden focal symptoms as an emergency, reconstruct time accurately, image tissue and vessels, identify mechanism, and prevent recurrence immediately.

Key points#

• Sudden resolved unilateral weakness or language change remains a neurovascular emergency.
• A normal examination and noncontrast CT do not exclude minor ischemic stroke or TIA.
• Brain and head-and-neck vascular imaging can reveal tissue injury and a treatable mechanism.
• Risk scores support but do not replace imaging, mechanism, expert judgment, and feasible rapid follow-up.
• Antiplatelet, anticoagulation, and carotid strategies depend on the cause and should not be stacked automatically.
• Every pending rhythm, vascular, laboratory, and medication transition needs a named owner and recurrent-symptom emergency plan.